FREE Case Review (866) 588-0600

Plaintiffs Lawyers Request MDL for Farxiga Lawsuits

A motion has been entered to consolidate all federal lawsuits filed over Farxiga into a single jurisdiction for pretrial handling.

A motion has been entered to consolidate all federal lawsuits filed over the type 2 diabetes drug Farxiga (generic: dapagliflozin) into a single jurisdiction for pretrial handling.

Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Farxiga side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the Problem?

February 22, 2017 – In a motion to transfer (PDF) filed earlier this month with the U.S. Judicial Panel on Multidistrict Litigation (JPML), plaintiffs requested that all federal lawsuits filed over injuries alleged from Farxiga be centralized for pretrial handling in the U.S. District Court of the Eastern District of Pennsylvania.

Multidistrict litigations are common in pharmaceutical litigation where a large number of lawsuits are filed alleging similar injuries from the same medication. Consolidation is intended to reduce duplicative discovery, avoid conflicting rulings by different judges, and to expedite the litigation process for all parties.

Farxiga is used to control blood sugar levels in patients with type 2 diabetes. It belongs to a class of medications called SGLT2 inhibitors that work by increasing the removal of sugar from the kidneys. Farxiga was released in a partnership between Bristol-Myers Squibb and AstraZeneca, and approved by the U.S. Food & Drug Administration (FDA) on January 8, 2014.

In December 2015, FDA issued a Drug Safety Communication stating that SGLT2 inhibitor diabetes drugs had been linked to reports of diabetic ketoacidosis (DKA), a life-threatening condition that occurs when cells in the body are unable to get the glucose they need for energy. The agency required information about the DKA risk to be added to the labeling of all SGLT2 inhibitors, warning users to discontinue use and seek immediate medical attention if they notice symptoms of rising acid levels in the blood.

Do I Have a Farxiga Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Farxiga lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

Free Case Evaluation: Again, if you or a loved one was injured by the side effects of Farxiga (generic: dapagliflozin), you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition